Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Charlie Smith who wrote (493)	4/15/1998 6:25:00 PM
From: Jim Mac	Read Replies (3) \| Respond to of 1754

$0.27 estimate assumed 40% tax rate, but even at 40%, Visx would have blown away estimates with $0.45 fully-taxed. And vast majority of revs go straight to Visx, not PPP. Going forward, equipment sales fluctuations will have virtually no effect on earnings, as pure-profit procedure revenue growth makes up the difference. And Visx laser users are kicking ass--look at LVCI, doing 3000 procedures a month on 23 lasers--that's 1500 annualized per laser. LZRCF and LCAV are also doing well with mostly Visx lasers. This means 1998 EPS of AT LEAST $2.00 fully-taxed, $2.50+ at current tax rate, with upside from S2 Smoothscan sales. Dissolution of PPP will ADD to earnings even more. I see $70 by year end, $40-50 by summer. Oh BABY.